Skip to main content
. Author manuscript; available in PMC: 2007 Oct 31.
Published in final edited form as: Neurosci Lett. 2007 Jul 19;423(2):89–94. doi: 10.1016/j.neulet.2007.05.067

Fig. 2.

Fig. 2

CNTF upregulated VIP immunoreactivity in human CE cells in situ. Corneoscleral explants treated with 0 M (A & C) and 2.1 × 10-9 M (B & D) CNTF were sectioned and stained with either anti-VIP (A&B) or rabbit IgG (C&D) as a control. The same result was obtained in five experiments, using five fresh eyes from four donors. Arrow: CE cells.